Tegginamani Anand Siddappa, Shivakumar Vanishree Halasagundhi, Kallarakkal Thomas George, Ismail Siti Mazlipah, Abraham Mannil Thomas, Bin Zamzuri Ahmad Termizi
Faculty of dentistry SEGi University Kota kamansara, Klang, Malaysia.
Faculty of Dentistry, University of Malaya, Klang, Malaysia.
J Oral Maxillofac Pathol. 2020 May-Aug;24(2):400. doi: 10.4103/jomfp.JOMFP_272_19. Epub 2020 Sep 9.
Oral potentially malignant disorders have a risk for malignant transformation but are difficult to reliably identify and predict which patients are at the risk for malignant transformation. OCT4 has been hypothesized to play a key oncogenic driver in a variety of solid tumors. A deeper understanding of the aberrant molecular pathways which lead to carcinogenesis needs to be identified by the potential markers.
To assess the OCT4 stemness factor in oral leukoplakia for its potential risk to malignant transformation.
20 cases of oral leukoplakia were obtained from archives at Oral Cancer Research & Coordinating center (OCRCC) Malaysia Subjects and Methods: 20 cases of oral leukoplakia were assessed by OCT4 immunohistochemically. Oral squamous cell carcinoma was used as a control.
no expression of OCT 4 was observed in any cases of oral leukoplakia.
The molecular mechanisms of Oct4 regulation and in particular of its switch on and off in tissues depends upon its microenvironment, which makes it challenging in fundamental and applied research fields of regenerative medicine and cancer therapy. It's better that patients should undergo multiple biopsies for the early detection of malignant transformation with close follow-up during the first two to three years, a large amount of work remains to be done with multi-marker panel investigation, as cure rates have remained constant over three decades.
口腔潜在恶性疾病有恶变风险,但难以可靠地识别和预测哪些患者有恶变风险。OCT4被认为在多种实体瘤中起关键致癌驱动作用。需要通过潜在标志物来更深入了解导致癌变的异常分子途径。
评估口腔白斑中OCT4干性因子对恶变的潜在风险。
从马来西亚口腔癌研究与协调中心(OCRCC)档案中获取20例口腔白斑病例。研究对象与方法:采用免疫组织化学方法对20例口腔白斑进行OCT4评估。以口腔鳞状细胞癌作为对照。
在任何口腔白斑病例中均未观察到OCT4表达。
Oct4调控的分子机制,尤其是其在组织中的开启和关闭,取决于其微环境,这在再生医学和癌症治疗的基础和应用研究领域具有挑战性。患者最好在前两到三年进行多次活检以早期发现恶变并密切随访,由于三十多年来治愈率一直保持不变,因此在多标志物组合研究方面仍有大量工作要做。